Pfizer (PFE) Q4 2023 Earnings Call Transcript : vimarsana.co

PFE earnings call for the period ending December 31, 2023.

Related Keywords

France , Germany , China , Japan , Australia , Canada , Kerry Holford , Chris Shibutani Goldman Sachs , David Risinger Leerink , Akash Tewari , Akash Tewari Jefferies , Terence Flynn Morgan Stanley , Rajesh Kumar , Carter Gould Barclays , Chris Schott , Andrew Baum , Geoff Meacham , Aamir Malik , David Risinger , Louise Chen Cantor Fitzgerald , Robyn Karnauskas Truist , Trung Huynh , Terence Flynn , Robyn Karnauskas , Chris Shibutani , Dave Denton , Mikael Dolsten , Evan Seigerman , America Merrill Lynch , Chris Boshoff , Mohit Bansal , Steve Scala , Carter Gould , Francesca Demartino , Chris Schott Jpmorgan , Andrew Baum Citi , Rd Doug Lankler , Albert Bourla , Kerry Holford Berenberg , Tim Anderson , Louise Chen , Geoff Meacham Bank , European Commission , Company Analyst , Goldman Sachs , Wells Fargo , Wolfe Research , Barclays , Vaccine Technical Committee , Pfizer International , Morgan Stanley , Pfizer , Tim Anderson Wolfe Research Analyst , Vice President , Chief Investor Relations , Motley Fool Stock Advisor , Stock Advisor , Alexandre De Germay , Chief Executive , Pfizer Oncology Innovation Day , Internal Medicine Metabolic Diseases , Pfizer International Commercial , Chief International Commercial , Vaccine Technical , Scientific Officer , Fast Track , Umer Raffat , Chief Oncology , Fargo Securities , Capital Markets , Commercial Officer , Cantor Fitzgerald , Chief Business , Executive Vice President , Wells Fargo Securities , Berenberg Capital Markets , Chief Executive Officer , Samir Malik ,